Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]

B. Braun and CytoSorbents Announce Global Co-Marketing Agreement

B. Braun Group on LinkedIn: #era #hemodialysisconcentrate #renalcare #dialysis…

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®

B. Braun Avitum Company Profile: Valuation, Investors, Acquisition

Continuous Renal Replacement Therapy (CRRT) Market Drivers & Opportunities

Organization

World premiere: Viva Frida Kahlo – Immersive Experience

B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement

Hip Replacement Devices Market Size, Share, Trends, Scope & Forecast